Spectroscopy Since 1975

Waters introduces the SARS-CoV-2 LC-MS kit

28 May 2021 | Product
by Ian Michael

Waters has introduced a new research use only LC-MS, the SARS-CoV-2 LC-MS Kit, which uses an orthogonal analytical method that directly detects and quantifies SARS-CoV-2 Nucleocapsid (NCAP) peptides that initial studies have shown to yield highly accurate, quantitative results. Waters developed the kit in support of a coalition of academic, commercial and government research scientists. This coalition worked to develop an alternative test method on LC-MS platforms in support of the United Kingdom’s National Health Service (NHS) Test & Trace programme. Their goal was to create a complementary, high-throughput screening method that would also use different reagents to help relieve strain on the PCR reagent supply chain.

Request Information about this Product

By submitting this form you agree that we may pass this information to the company who you are enquiring about.

Request Quote for this Product

By submitting this form you agree that we may pass this information to the company you are requesting the quote from.